Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0002056093-26-000002

Chief Medical Officer acquired 24,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Markus Richard Chief Medical Officer 2026-01-23 Grant or award +24,000 89,647 D
Derivatives
Markus Richard Chief Medical Officer 2026-01-23 Grant or award · Stock Option (right to buy) +96,000 96,000 D
Loading xslF345X05/wk-form4_1769476911.xml…